Exact Mass: 393.1012458
Exact Mass Matches: 393.1012458
Found 270 metabolites which its exact mass value is equals to given mass value 393.1012458
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
amsacrine
C21H19N3O3S (393.11470640000005)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents
Dihydromacarpine
C22H19NO6 (393.12123140000006)
A benzophenanthridine alkaloid that is dihydrosanguinarine bearing two methoxy substituents.
Tifluadom
C22H20FN3OS (393.13110420000004)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D02694
Fruquintinib
C21H19N3O5 (393.13246440000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Homidium bromide
C21H20N3. Br (393.08405000000005)
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors
(S)-N1-(2-(tert-butyl)-4-methyl-[4,5-bithiazol]-2-yl)pyrrolidine-1,2-dicarboxamide
gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine
C14H23N3O8S (393.12057980000003)
gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine is found in onion-family vegetables. gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine is a constituent of onion (Allium cepa) and garlic (Allium sativum) Constituent of onion (Allium cepa) and garlic (Allium sativum). gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine is found in garden onion, garlic, and onion-family vegetables.
Amsacrine
C21H19N3O3S (393.11470640000005)
Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem] C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents
(gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine
C14H23N3O8S (393.12057980000003)
(gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine is found in pulses. (gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine is a constituent of the seeds of Vigna radiata (mung bean). Constituent of the seeds of Vigna radiata (mung bean). (gamma-Glutamyl-gamma-glutamyl)-S-methylcysteine is found in pulses.
Besifloxacin
C19H21ClFN3O3 (393.12553980000007)
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride
C18H23N3O5S (393.13583480000005)
Lorzafone
C18H17Cl2N3O3 (393.0646912000001)
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
Q-100035
1-[5-(2-Cyclopropyl-5,7-dimethylimidazo[4,5-b]pyridin-3-ylmethyl)thiophen-2-yl]cyclopent-3-ene carboxylic acid
4-(2-Aminoethylamino)-3-[bis(carboxymethyl)amino]-3-(carboxymethyl)hexanedioic acid
6,6-Dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
Rubitecan
Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone. Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].
5-(2-Chloro-6-fluorobenzyl)-6-methyl-2-(prop-2-ynylthio)pyrimidin-4-yl N,N-dimethylcarbamate
3,5-bis(Acetyloxy)-2-(1,3-benzothiazol-2-yl)tetrahydro-2H-pyran-4-yl acetate
AMG-073 HCl (Cinacalcet hydrochloride)
C22H23ClF3N (393.14710240000005)
S-(2-Carboxypropyl)glutathione
C14H23N3O8S (393.12057980000003)
Annotation level-3
Glutamyl-S-(C4H7O2)-cysteinylglycine
C14H23N3O8S (393.12057980000003)
Annotation level-3
Ala Cys Asn Ser
C13H23N5O7S (393.13181280000003)
Ala Cys Ser Asn
C13H23N5O7S (393.13181280000003)
Ala Asn Cys Ser
C13H23N5O7S (393.13181280000003)
Ala Asn Ser Cys
C13H23N5O7S (393.13181280000003)
Ala Ser Cys Asn
C13H23N5O7S (393.13181280000003)
Ala Ser Asn Cys
C13H23N5O7S (393.13181280000003)
Cys Ala Asn Ser
C13H23N5O7S (393.13181280000003)
Cys Ala Ser Asn
C13H23N5O7S (393.13181280000003)
Cys Gly Asn Thr
C13H23N5O7S (393.13181280000003)
Cys Gly Gln Ser
C13H23N5O7S (393.13181280000003)
Cys Gly Ser Gln
C13H23N5O7S (393.13181280000003)
Cys Gly Thr Asn
C13H23N5O7S (393.13181280000003)
Cys Asn Ala Ser
C13H23N5O7S (393.13181280000003)
Cys Asn Gly Thr
C13H23N5O7S (393.13181280000003)
Cys Asn Ser Ala
C13H23N5O7S (393.13181280000003)
Cys Asn Thr Gly
C13H23N5O7S (393.13181280000003)
Cys Gln Gly Ser
C13H23N5O7S (393.13181280000003)
Cys Gln Ser Gly
C13H23N5O7S (393.13181280000003)
Cys Ser Ala Asn
C13H23N5O7S (393.13181280000003)
Cys Ser Gly Gln
C13H23N5O7S (393.13181280000003)
Cys Ser Asn Ala
C13H23N5O7S (393.13181280000003)
Cys Ser Gln Gly
C13H23N5O7S (393.13181280000003)
Cys Thr Gly Asn
C13H23N5O7S (393.13181280000003)
Cys Thr Asn Gly
C13H23N5O7S (393.13181280000003)
Gly Cys Asn Thr
C13H23N5O7S (393.13181280000003)
Gly Cys Gln Ser
C13H23N5O7S (393.13181280000003)
Gly Cys Ser Gln
C13H23N5O7S (393.13181280000003)
Gly Cys Thr Asn
C13H23N5O7S (393.13181280000003)
Gly Asn Cys Thr
C13H23N5O7S (393.13181280000003)
Gly Asn Thr Cys
C13H23N5O7S (393.13181280000003)
Gly Gln Cys Ser
C13H23N5O7S (393.13181280000003)
Gly Gln Ser Cys
C13H23N5O7S (393.13181280000003)
Gly Ser Cys Gln
C13H23N5O7S (393.13181280000003)
Gly Ser Gln Cys
C13H23N5O7S (393.13181280000003)
Gly Thr Cys Asn
C13H23N5O7S (393.13181280000003)
Gly Thr Asn Cys
C13H23N5O7S (393.13181280000003)
Asn Ala Cys Ser
C13H23N5O7S (393.13181280000003)
Asn Ala Ser Cys
C13H23N5O7S (393.13181280000003)
Asn Cys Ala Ser
C13H23N5O7S (393.13181280000003)
Asn Cys Gly Thr
C13H23N5O7S (393.13181280000003)
Asn Cys Ser Ala
C13H23N5O7S (393.13181280000003)
Asn Cys Thr Gly
C13H23N5O7S (393.13181280000003)
Asn Gly Cys Thr
C13H23N5O7S (393.13181280000003)
Asn Gly Thr Cys
C13H23N5O7S (393.13181280000003)
Asn Ser Ala Cys
C13H23N5O7S (393.13181280000003)
Asn Ser Cys Ala
C13H23N5O7S (393.13181280000003)
Asn Ser Ser Ser
Asn Thr Cys Gly
C13H23N5O7S (393.13181280000003)
Asn Thr Gly Cys
C13H23N5O7S (393.13181280000003)
Gln Cys Gly Ser
C13H23N5O7S (393.13181280000003)
Gln Cys Ser Gly
C13H23N5O7S (393.13181280000003)
Gln Gly Cys Ser
C13H23N5O7S (393.13181280000003)
Gln Gly Ser Cys
C13H23N5O7S (393.13181280000003)
Gln Ser Cys Gly
C13H23N5O7S (393.13181280000003)
Gln Ser Gly Cys
C13H23N5O7S (393.13181280000003)
Ser Ala Cys Asn
C13H23N5O7S (393.13181280000003)
Ser Ala Asn Cys
C13H23N5O7S (393.13181280000003)
Ser Cys Ala Asn
C13H23N5O7S (393.13181280000003)
Ser Cys Gly Gln
C13H23N5O7S (393.13181280000003)
Ser Cys Asn Ala
C13H23N5O7S (393.13181280000003)
Ser Cys Gln Gly
C13H23N5O7S (393.13181280000003)
Ser Gly Cys Gln
C13H23N5O7S (393.13181280000003)
Ser Gly Gln Cys
C13H23N5O7S (393.13181280000003)
Ser Asn Ala Cys
C13H23N5O7S (393.13181280000003)
Ser Asn Cys Ala
C13H23N5O7S (393.13181280000003)
Ser Asn Ser Ser
Ser Gln Cys Gly
C13H23N5O7S (393.13181280000003)
Ser Gln Gly Cys
C13H23N5O7S (393.13181280000003)
Ser Ser Asn Ser
Ser Ser Ser Asn
Thr Cys Gly Asn
C13H23N5O7S (393.13181280000003)
Thr Cys Asn Gly
C13H23N5O7S (393.13181280000003)
Thr Gly Cys Asn
C13H23N5O7S (393.13181280000003)
Thr Gly Asn Cys
C13H23N5O7S (393.13181280000003)
Thr Asn Cys Gly
C13H23N5O7S (393.13181280000003)
Thr Asn Gly Cys
C13H23N5O7S (393.13181280000003)
5-Hydroxythiabendazole glucuronide
C16H15N3O7S (393.06306800000004)
Pentetic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
gamma-L-Glutamyl-S-(2-carboxy-1-propyl)cysteinylglycine
C14H23N3O8S (393.12057980000003)
(g-Glutamyl-g-glutamyl)-S-methylcysteine
C14H23N3O8S (393.12057980000003)
2,3,5-Tri-O-acetyladenosine
2’,3’,5’-Tri-O-acetyl adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
Sulfaloxic acid
C16H15N3O7S (393.06306800000004)
C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
7-FLUORO-3,4-DIHYDRO-4-[(5-ISOQUINOLINYLOXY)ACETYL]-1,3,3-TRIMETHYL-2(1H)-QUINOXALINONE
C22H20FN3O3 (393.14886220000005)
2,6-BIS((3AS,8AR)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE
N-FMOC-5-AMINO-2-CHLOROBENZOIC ACID
C22H16ClNO4 (393.07678060000006)
4-(4-(4-BROMO-2,6-DIMETHYLPHENYLAMINO)PYRIMIDIN-2-YLAMINO)BENZONITRILE
Benzyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate
C22H19NO6 (393.12123140000006)
2-amino-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone 4-Methylbenzenesulfonate
C16H15F4NO4S (393.06578780000007)
Cinacalcet hydrochloride
C22H23ClF3N (393.14710240000005)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents
6-methoxy-3-methyl-2-[3-methyl-3-(4-nitrophenyl)triazen-1-yl]benzothiazolium chloride
C16H16ClN5O3S (393.06623360000003)
2-[2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazol-4-yl]acetic acid
methyl 2-[(3-cyanobenzoyl)amino]-3-(3-methoxypropyl)imidazo[4,5-b]pyridine-6-carboxylate
C20H19N5O4 (393.14369740000006)
1-(3,5-DIMETHYL-4-ETHYL-PYRROL-2-YL)-3-(3,5-DIMETHYL-4-ETHYL-PYRROLIUM-2-YLIDENE)-CYCLOBUTEN-2-ONE-4-OLATE
O-[BIS(4-METHOXYPHENYL)PHOSPHINYL]-N-(TERT-BUTOXYCARBONYL)HYDROXYLAMINE
C19H24NO6P (393.13411740000004)
3-(4-Bromophenoxy)-1-(diphenylmethyl)-azetidine
C22H20BrNO (393.07281700000004)
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine
(E)-2,4,6-triMethoxystyryl-4-Methoxy-3-aminobenzylsulfone, (E)-5-((2,4,6-triMethoxystyrylsulfonyl)Methyl)-2-Methoxybenzeneamine
C19H23NO6S (393.12460180000005)
Bendamustine
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents
Besifloxacin
C19H21ClFN3O3 (393.12553980000007)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
BENZYL 5-(BENZYLOXY)-4-METHOXY-2-NITROBENZOATE
C22H19NO6 (393.12123140000006)
Rosiglitazone HCl
C18H20ClN3O3S (393.09138400000006)
Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].
2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-CHLOROBENZOIC ACID
C22H16ClNO4 (393.07678060000006)
N-FMOC-4-AMINO-2-CHLOROBENZOIC ACID
C22H16ClNO4 (393.07678060000006)
BOC-THIONOLEU-1-(6-NITRO)BENZOTRIAZOLIDE
C17H23N5O4S (393.14706780000006)
Fmoc-(R)-3-Amino-3-(2-thienyl)-propionic acid
C22H19NO4S (393.1034734000001)
7-[(3R)-3-isothiocyanatopyrrolidin-1-yl]-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide
2,6-BIS((3AR,8AS)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE
4,4,4-(1,3,5-Triazine-2,4,6-triyl)tris[benzaldehyde]
C24H15N3O3 (393.11133600000005)
Testolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent
4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide
PF-4191834 (PF-04191834) is an orally active, noniron chelating, and non-redox inhibitor of the 5-Lipoxygenase (5-LOX) (IC50=229 nM), displays ~300-fold selectivity for 5-LOX over 12-LOX and 15-LOX, shows no activity toward the cyclooxygenase enzymes, and is effective in inflammation and pain[1].
2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]pyrazolo[1,5-b]pyridazine
C21H19N3O3S (393.11470640000005)
N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride
C18H23N3O5S (393.13583480000005)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors
2-(Biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid
C22H19NO4S (393.1034734000001)
2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide
C22H20FN3O3 (393.14886220000005)
4-{2-[(4-fluorophenyl)sulfonyl]acetyl}-2,6-dimethylphenyl N,N-dimethylcarbamate
C19H20FNO5S (393.10461620000007)
4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide
C18H20ClN3O3S (393.09138400000006)
N-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide
C21H19N3O3S (393.11470640000005)
2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime
2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime
1-(3,4-dihydro-2H-quinolin-1-yl)-2-[[1-(4-ethoxyphenyl)-2-imidazolyl]thio]ethanone
N,N-dimethylcarbamothioic acid O-[4-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,6-dimethylphenyl] ester
C19H20ClNO2S2 (393.06239300000004)
N-[3-chloro-4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]phenyl]pyridine-2-carboxamide
C21H16ClN3O3 (393.08801360000007)
Aluminum nicotinate
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AD - Nicotinic acid and derivatives
Rel-(9R,12S)-9,10,11,12-tetrahydro-9,12-epoxy-1H-diindolo[1,2,3-FG:3,2,1-KL]pyrrolo[3,4-I][1,6]benzodiazocine-1,3(2H)-dione
C24H15N3O3 (393.11133600000005)
3-{[(2,2-Dioxido-1,3-dihydro-2-benzothien-5-YL)amino]methylene}-5-(1,3-oxazol-5-YL)-1,3-dihydro-2H-indol-2-one
C20H15N3O4S (393.07832300000007)
N-{3-[(3-methoxyphenyl)carbamoyl]-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl}pyridine-3-carboxamide
C21H19N3O3S (393.11470640000005)
4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine
3-Carboxy-2,7-dihydroxy-9-methoxy-4-methyl-6,11-dioxotetracen-5-olate
5-methyl-4-oxo-2-(2-oxopropyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-7-olate
C19H21O9- (393.11855160000005)
5-Ethyl-3-imino-6-phenylphenanthridin-8-amine;hydrobromide
C21H20BrN3 (393.08405000000005)
Homidium bromide
C21H20BrN3 (393.08405000000005)
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-methoxybenzamide
C17H13F6NO3 (393.07995800000003)
1-[7-Acetyl-5-(4-bromo-benzoyl)-1,3,7-triaza-bicyclo[3.3.1]non-3-yl]-ethanone
n-[2-(4-Phenoxybenzyl)benzimidazol-5-yl]methanesulphonamide
C21H19N3O3S (393.11470640000005)
N-[4-(4-morpholinyl)phenyl]-5-(2-nitrophenyl)-2-furancarboxamide
C21H19N3O5 (393.13246440000006)
2-[[5,6-Bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-1-(4-methoxyphenyl)ethanone
C20H15N3O4S (393.07832300000007)
4-[(Z)-[1-(4-cyanophenyl)-5-oxo-3-phenylpyrazol-4-ylidene]methyl]benzoic acid
C24H15N3O3 (393.11133600000005)
Isopropyl 6-methyl-2-[(phenylsulfonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
C19H23NO4S2 (393.10684380000004)
3-{[1-(3-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidenemethyl]-amino}-2-methyl-3H-quinazolin-4-one
1-[4-(4-Phenylmethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide
N-(3-imidazol-1-ylpropyl)-2-[(4-nitrobenzoyl)amino]benzamide
C20H19N5O4 (393.14369740000006)
2-(3,4-Dimethoxyphenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
C22H19NO6 (393.12123140000006)
2-[1-[[[(4-Methoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]-3-oxo-2-piperazinyl]acetic acid propan-2-yl ester
C18H23N3O5S (393.13583480000005)
N-{(E)-[2,4,6-trioxo-1-(2,4,6-trimethylphenyl)tetrahydropyrimidin-5(2H)-ylidene]methyl}pyridine-4-carbohydrazide
C20H19N5O4 (393.14369740000006)
5-Ethyl-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester
C19H23NO6S (393.12460180000005)
8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one
N-[(3-bromo-4-ethoxy-5-methoxyphenyl)methyl]-2,3-dihydro-1,4-benzodioxin-6-amine
C18H20BrNO4 (393.0575620000001)
5-[1-Benzyl-2-methyl-6-(trifluoromethyl)pyridin-4-ylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione
C18H14F3N3O2S (393.07587800000005)
3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide
C21H16ClN3O3 (393.08801360000007)
2-[(3-cyano-4-phenyl-6-thiophen-2-yl-2-pyridinyl)thio]-N-propan-2-ylacetamide
C21H19N3OS2 (393.09694840000003)
N-[2,5-diethoxy-4-[[ethylamino(sulfanylidene)methyl]amino]phenyl]-2-thiophenecarboxamide
(3E)-3-{2-[(4-methoxyphenyl)carbonyl]hydrazinylidene}-N-[3-(trifluoromethyl)phenyl]butanamide
C19H18F3N3O3 (393.13001940000004)
(15R)-13-[(2-Chlorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
C22H20ClN3O2 (393.12439700000004)
1-(4-Chlorophenyl)-3-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]thiourea
C21H16ClN3OS (393.07025560000005)
[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone
C22H20FN3O3 (393.14886220000005)
(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2R,3S,4S)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide
C18H20FN3O4S (393.11584920000007)
(2S,3R,4R)-1-(5-ethyl-2-thiazolyl)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C22H20FN3OS (393.13110420000004)
[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone
C22H20FN3O3 (393.14886220000005)
2-[(2,5-dimethylphenyl)thio]acetic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester
C21H19N3O3S (393.11470640000005)
5-[[4-[(Z)-2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]furan-2-carboxylic acid
Cyclohexyl 2-methyl-4-thiophen-2-yl-3,4-dihydropyrimido[1,2-a]benzimidazole-3-carboxylate
(2S)-2-(3-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamide
C21H16ClN3O3 (393.08801360000007)
2-chloro-4-[[(1R)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
Tifluadom
C22H20FN3OS (393.13110420000004)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D02694
Agomelatine (L(+)-Tartaric acid)
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].
AKT Kinase Inhibitor (hydrochloride)
AKT Kinase Inhibitor hydrochloride is an Akt kinase inhibitor with anti-tumor activity[1]. AKT Kinase Inhibitor (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
CJ-13,610
CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimulated PMNL in the absence of exogenous AA with an IC50 of about 70 nM[1]. PMNL: polymorphonuclear leukocytes; AA: arachidonic acid
SCD1 inhibitor-3
C19H16FN7O2 (393.13494479999997)
SCD1 inhibitor-3 is a safe, potent and orally active SCD1 inhibitor. SCD1 inhibitor-3 can be used for the research of metabolic diseases such as obesity, type II diabetes and dyslipidemia, as well as skin diseases, acne and cancer[1].
(1r,2r,5s,8r)-5-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-11-methyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
(2s)-20-hydroxy-10,18-dimethoxy-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16,18,20-heptaene-7,15-dione
C21H19N3O5 (393.13246440000006)
10,19-dimethoxy-7,15-dioxo-6,14,22λ⁵-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁷,²²]docosa-1(22),8,10,12,16,18,20-heptaen-22-ylium-16-olate
C21H19N3O5 (393.13246440000006)